Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal replacement II: dialysis dose.

Zaccaria Ricci1, Claudio Ronco

  • 1Department of Anesthesiology and Intensive Care, University of Rome, La Sapienza, viale del Policlinico 155, 00161 Rome, Italy. z.ricci@libero.it

Critical Care Clinics
|March 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatorenal syndrome treated for eight months with continuous-flow peritoneal dialysis.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2013
Same author

Year in review 2012: Critical Care--Nephrology.

Critical care (London, England)·2013
Same author

Healthcare systems and chronic kidney disease: putting the patient in control.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2013
Same author

Neutrophil gelatinase associated lipocalin in acute kidney injury.

Postgraduate medicine·2013
Same author

Ultrafiltration therapy for acute decompensated heart failure: lessons learned from 2 major trials.

American heart journal·2013
Same author

Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.

Kidney international·2013
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

For critically ill acute renal failure patients, achieving an adequate dose of renal replacement therapy is crucial for survival. A Kt/V threshold of 1.4 is recommended, potentially requiring more frequent treatments for optimal solute elimination.

Area of Science:

  • Nephrology
  • Critical Care Medicine
  • Renal Replacement Therapy

Background:

  • Critically ill acute renal failure patients require effective solute removal.
  • Therapy dose is correlated with patient survival.
  • Current dialysis dose metrics may not fully capture optimal solute elimination.

Purpose of the Study:

  • To establish a recommended dialysis dose threshold for critically ill acute renal failure patients.
  • To evaluate the adequacy of solute elimination based on therapy dose.
  • To explore the role of treatment frequency in optimizing renal replacement therapy.

Main Methods:

  • Utilizing the product of clearance and time (Kt) normalized for the volume of distribution (V) as Kt/V to measure solute elimination.
  • Comparing a proposed Kt/V threshold with current chronic dialysis prescriptions.

Related Experiment Videos

  • Considering the diffusion characteristics of uremic toxins and the importance of treatment frequency.

    • Main Results:

    • A Kt/V threshold of 1.4 is suggested to guide clinicians toward adequate treatment for acute renal failure.
    • This recommended threshold is slightly higher than that for chronic dialysis.
    • Continuous therapy may be optimal due to slower diffusion of uremic toxins.

    Conclusions:

    • A Kt/V of 1.4 serves as a benchmark for adequate dialysis dose in critically ill acute renal failure.
    • Clinicians should consider exceeding calculated adequate doses when optimal treatment is uncertain.
    • Treatment frequency, particularly continuous therapy, is vital for efficient solute elimination in acute renal failure.